Gastrointestinal carcinoma – Life with Disease

Go back

Gastrointestinal carcinoma refers to cancers that develop anywhere along the digestive tract, from the mouth to the anus. These cancers can form in the esophagus, stomach, intestines, pancreas, liver, or other digestive organs, and while they share some common features, each type presents unique challenges for patients and their families.

Understanding the Outlook: Prognosis for Gastrointestinal Carcinoma

When someone receives a diagnosis of gastrointestinal carcinoma, one of the first questions that naturally comes to mind is about the future. The prognosis, or expected outcome, varies greatly depending on several important factors. Where the cancer is located in the digestive system, how early it was discovered, and how far it has spread all play crucial roles in determining what to expect[1].

For colorectal cancers, which are among the most common gastrointestinal cancers in the United States, early detection makes an enormous difference. When caught early, these cancers are highly curable. In fact, colorectal cancer is considered one of the most treatable forms of gastrointestinal cancer if diagnosed before it spreads to other organs[1]. This is why screening programs have become so important in recent years.

The stage at which cancer is discovered dramatically affects survival rates. For stomach cancer, when the disease has spread to other parts of the body (a condition called metastasis), the five-year survival rate drops significantly, to just 5%[15]. This stark difference highlights why early detection through screening and paying attention to symptoms matters so much.

Treatment advances in recent years have provided new hope. The development of immunotherapy drugs, which help the body’s own immune system fight cancer, and targeted therapies that attack specific features of cancer cells, have improved outcomes for many patients[14]. These newer approaches are being added to traditional treatments like surgery, chemotherapy, and radiation, giving doctors more tools to fight the disease.

⚠️ Important
Survival statistics are based on large groups of people and cannot predict what will happen to any individual patient. Your own situation depends on many personal factors, including your overall health, the specific characteristics of your cancer, and how well you respond to treatment. Always discuss your individual prognosis with your healthcare team, who can provide information specific to your case.

How the Disease Progresses Without Treatment

Understanding how gastrointestinal cancer develops naturally helps explain why treatment timing is so critical. Cancer begins when changes occur in the DNA of cells lining the digestive tract. These changes, called mutations, cause cells to grow out of control instead of following their normal life cycle[10].

In the digestive system, cancer typically starts in the innermost layer of tissue. For stomach cancer, about 95% of cases begin in the stomach lining and progress slowly at first[10]. Without treatment, these abnormal cells continue multiplying and form a mass or tumor. Over time, the tumor grows deeper into the stomach walls, penetrating through multiple layers of tissue.

As the cancer becomes more advanced, it doesn’t stay confined to its original location. Cancer cells can break away from the primary tumor and travel through the lymphatic system to nearby lymph nodes, which are small structures that filter fluid and help fight infection. From there, cancer may spread to distant organs. In gastrointestinal cancers, the liver and lungs are common sites where the disease spreads[10].

The progression timeline varies considerably. Some gastrointestinal cancers develop slowly over many years, which is why screening programs can be so effective at catching them early. Stomach cancer, for instance, typically develops slowly, allowing time for detection if regular check-ups are maintained. However, once symptoms become noticeable, the cancer is often already in a more advanced stage.

Colorectal cancer often begins as small growths called polyps on the inner lining of the colon or rectum. These polyps may take years to develop into cancer, which is why routine colonoscopy screenings that find and remove polyps can actually prevent cancer from forming at all[1].

Possible Complications and Challenges

Gastrointestinal carcinoma can lead to various complications that affect both quality of life and overall health. These complications arise from the tumor itself, from the cancer spreading, or sometimes from the effects of treatment.

One significant complication is blockage of the digestive tract. As tumors grow, they can physically obstruct the passage of food and liquid through the digestive system. In stomach cancer, a tumor might block the entrance to the stomach from the esophagus or the exit from the stomach into the small intestine[25]. This causes severe pain, nausea, vomiting, and an inability to eat properly, leading to malnutrition and rapid weight loss.

Bleeding represents another serious complication. Tumors in the digestive tract can erode blood vessels, causing bleeding that may be visible in vomit or stool. Sometimes the bleeding is slow and hidden, leading to anemia (low red blood cell count), which causes fatigue, weakness, and shortness of breath. Black or tarry stools often signal bleeding higher up in the digestive tract[10].

Nutritional problems commonly develop as gastrointestinal cancer progresses. The cancer itself can change how the body uses energy from food, causing it to burn calories at a faster rate. Combined with decreased food intake due to loss of appetite, pain, or blockages, this leads to significant weight loss and weakness[21]. After surgery to remove part or all of the stomach, patients may struggle to absorb nutrients properly, requiring careful attention to diet and sometimes nutritional supplements.

A condition called dumping syndrome can occur after stomach surgery. This happens when food moves too quickly from the stomach (or what remains of it) into the small intestine, causing nausea, diarrhea, sweating, and feeling faint after eating[21]. While uncomfortable, strategies exist to manage this condition through dietary modifications.

When cancer spreads to other organs, it can cause organ-specific complications. Spread to the liver can lead to jaundice (yellowing of the skin and eyes), abdominal swelling, and liver dysfunction. Spread to the lungs can cause breathing difficulties and persistent cough. Spread to the bones may result in severe pain and increased risk of fractures.

Impact on Daily Life and Activities

Living with gastrointestinal carcinoma affects nearly every aspect of daily life. The physical symptoms, treatment side effects, and emotional burden combine to create challenges that extend far beyond medical appointments.

Eating, one of life’s most basic activities, often becomes complicated. Many people with gastrointestinal cancer experience a profound loss of appetite. The disease itself can make food unappealing, and symptoms like nausea, pain, or feeling full after eating very little make mealtimes stressful rather than enjoyable[21]. Social situations that involve food, like family dinners or restaurant outings, may become sources of anxiety or discomfort.

For those who have undergone surgery, particularly removal of part or all of the stomach, eating requires significant adjustments. Patients must learn to eat smaller, more frequent meals instead of three regular meals a day. Some foods that were previously enjoyed may now cause discomfort or digestive problems. The social and emotional aspects of sharing meals with others can be lost when eating becomes primarily functional rather than pleasurable[26].

Physical energy and strength often decline. Fatigue is one of the most common and overwhelming symptoms of advanced cancer. This isn’t ordinary tiredness that improves with rest; it’s a profound exhaustion that can make even simple tasks feel impossible[25]. Getting out of bed, showering, or preparing a meal may require more effort than patients have available.

Work life frequently suffers. The demanding schedule of treatments, which might include chemotherapy every two weeks and various medical appointments, makes maintaining regular employment challenging[24]. Treatment side effects like nausea, pain, or extreme fatigue can make it difficult to concentrate or perform job duties. Some patients must reduce their hours, take extended leave, or stop working entirely, adding financial stress to their other burdens.

Hobbies and leisure activities that once brought joy may need to be modified or temporarily abandoned. Physical activities become more difficult due to weakness and fatigue. Social activities may be limited by unpredictable symptoms or the need to stay close to bathroom facilities if diarrhea is a problem.

The emotional and mental health impact cannot be understated. Anxiety about the future, fear of cancer progression, worry about becoming a burden to loved ones, and grief over lost abilities and independence are common. Depression may develop, particularly when pain is poorly controlled or when social connections diminish[19].

Despite these challenges, many people find ways to adapt and maintain quality of life. Working closely with a healthcare team that includes not just oncologists but also dietitians, pain specialists, social workers, and mental health professionals can help address these various challenges. Some patients discover new strengths and appreciate aspects of life they previously took for granted.

⚠️ Important
Speaking up about problems and symptoms is essential. Healthcare teams can only help with issues they know about. Medications can control pain and nausea. Dietitians can suggest strategies to maintain nutrition. Social workers can connect you with resources for practical and financial assistance. Don’t suffer in silence when help may be available.

Supporting Family Members and Loved Ones

Family members and close friends play a crucial role when someone is dealing with gastrointestinal carcinoma, especially when considering participation in clinical trials. Understanding how to provide effective support requires knowledge about what clinical trials are and how they work.

Clinical trials are research studies that test new approaches to treating, detecting, or preventing disease. For gastrointestinal cancers, clinical trials might evaluate new chemotherapy drugs, innovative surgical techniques, immunotherapy treatments, or combinations of different therapies. These studies are essential for medical progress, and patients who participate often gain access to cutting-edge treatments before they become widely available.

Family members can help by learning about clinical trials alongside their loved one. Many people feel overwhelmed when first diagnosed, and having a family member who can research options, ask questions during appointments, and help organize information can be invaluable. Websites like those maintained by the National Cancer Institute provide searchable databases of ongoing clinical trials for various types of cancer.

Understanding the phases of clinical trials helps families support informed decision-making. Early-phase trials test whether new treatments are safe and determine appropriate doses. Later-phase trials compare new treatments to standard treatments to see if they work better. Each phase serves an important purpose, and families should discuss with the medical team what phase of trial might be appropriate and what the goals would be.

Practical support during trial participation is crucial. Clinical trials often require frequent hospital or clinic visits, sometimes more often than standard treatment. Family members can help by providing transportation, attending appointments to take notes and ask questions, keeping track of side effects, and helping the patient follow the trial protocol correctly.

Emotional support during trial participation is equally important. Patients may experience hope, fear, disappointment, or uncertainty about whether they received the experimental treatment or a standard treatment (in trials that include a comparison group). Family members who listen without judgment, offer encouragement, and help maintain perspective provide essential psychological support.

Families should also help patients understand their rights in clinical trials. Participation is always voluntary, and patients can withdraw at any time without affecting their access to standard care. Informed consent documents explain all risks and benefits, and patients should never feel pressured to participate. Family members can help review these documents and ensure all questions are answered before making decisions.

Financial considerations matter too. While the experimental treatment in a trial is typically provided free, other costs like routine care, travel, lodging, and time away from work still apply. Some trials offer assistance with these expenses. Families can help research what support might be available and how to access it.

Beyond clinical trials, families provide daily support that makes a tremendous difference. This includes helping with practical tasks that become difficult, like grocery shopping, meal preparation, and household chores. It means being present, even when there’s nothing to say or do except sit quietly together. It involves advocating for the patient’s needs with healthcare providers and helping navigate complex medical systems.

Caregivers must also remember to care for themselves. The stress of watching a loved one struggle with cancer can lead to exhaustion, anxiety, and depression in family members. Seeking support for themselves through counseling, support groups, or respite care isn’t selfish; it’s necessary to sustain their ability to help over the long term.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Ramucirumab (Cyramza®) – A monoclonal antibody that targets the VEGF/VEGFR2 pathway to inhibit tumor blood vessel growth; approved for subsets of patients with advanced stomach or gastroesophageal cancer
  • Trastuzumab (Herceptin®) – A monoclonal antibody that targets the HER2 pathway; approved for subsets of patients with advanced, HER2-positive gastroesophageal cancer
  • Trastuzumab deruxtecan (Enhertu®) – An antibody-drug conjugate that targets the HER2 pathway; approved for subsets of patients with advanced stomach or gastroesophageal cancer
  • Dostarlimab (Jemperli) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced stomach or gastroesophageal cancer that has DNA mismatch repair deficiency (dMMR)
  • Nivolumab (Opdivo®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced stomach or gastroesophageal cancer
  • Pembrolizumab (Keytruda®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway; approved for subsets of patients with advanced stomach or gastroesophageal cancer

Ongoing Clinical Trials on Gastrointestinal carcinoma

  • Study of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Finland France Germany Italy The Netherlands +4
  • Study on the Safety of Lanreotide and Metformin for Patients with Advanced Gastrointestinal or Lung Carcinoids

    Recruiting

    1 1 1
    Italy
  • Study on Capecitabine and Oxaliplatin for Patients with Advanced or Metastatic Gastrointestinal Cancer with CES1 Variant

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • A Study Using Indocyanine Green Fluorescence Imaging to Help Surgeons Better Identify Tumor Edges During Cancer Surgery in Patients with Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of Domvanalimab, Zimberelimab, and Quemliclustat in Adults with Advanced Upper Gastrointestinal Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    France

References

https://www.yalemedicine.org/conditions/gastrointestinal-cancers

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/symptoms-causes/syc-20352438

https://gi.org/topics/gastrointestinal-cancers/

https://www.cancer.gov/types/stomach

https://www.ncbi.nlm.nih.gov/books/NBK586002/

https://www.dignityhealth.org/conditions-and-treatments/oncology/gastrointestinal-cancer

https://kskcancercenter.com/conditions_gastrointestinal

https://cancer.stonybrookmedicine.edu/GICancer/Types

https://www.tgh.org/institutes-and-services/conditions/gastrointestinal-cancer

https://my.clevelandclinic.org/health/diseases/15812-stomach-cancer

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://www.cancer.gov/types/stomach/treatment

https://www.cancer.org/cancer/types/stomach-cancer/treating/by-stage.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC9927927/

https://www.cancerresearch.org/immunotherapy-by-cancer-type/stomach-cancer

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/treatment

https://www.mskcc.org/cancer-care/types/stomach-gastric/treatment

https://my.clevelandclinic.org/health/diseases/15812-stomach-cancer

https://www.cancer.gov/types/stomach/coping

https://www.cancercare.org/publications/235-coping_with_stomach_cancer

https://cancer.ca/en/cancer-information/cancer-types/stomach/supportive-care/nutrition-and-stomach-cancer

https://www.medstarhealth.org/blog/toby-keith-stomach-cancer

https://www.cancer.org/cancer/types/stomach-cancer/after-treatment/follow-up.html

https://health.clevelandclinic.org/coping-with-stomach-cancer-changes

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/treatment/controlling-symptoms

https://www.foxchase.org/blog/2017-2811-life-without-a-stomach-staying-healthy-after-surgery

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can gastrointestinal cancer be prevented?

While not all gastrointestinal cancers can be prevented, you can significantly reduce your risk through healthy lifestyle choices. Regular exercise, maintaining a healthy weight, eating a diet rich in fruits and vegetables while limiting red meat and processed foods, avoiding tobacco, and moderating alcohol consumption all help reduce risk. For colorectal cancer specifically, routine screening can actually prevent cancer by finding and removing polyps before they become cancerous.

What are the early warning signs of stomach cancer I should watch for?

Unfortunately, stomach cancer often doesn’t cause symptoms in early stages. When symptoms do appear, they may include unexplained weight loss, stomach pain (particularly above the belly button), loss of appetite, feeling full after eating small amounts, persistent heartburn or indigestion, nausea, and difficulty swallowing. If you notice these symptoms persisting, especially if you have risk factors like H. pylori infection or family history, consult your doctor promptly.

Is stomach cancer hereditary?

While most stomach cancers occur sporadically and are not inherited, about 5 to 10 percent of colorectal cancers result from inherited genetic risk factors. Certain genetic conditions like hereditary diffuse gastric cancer syndrome, Lynch syndrome, and familial adenomatous polyposis increase stomach cancer risk. Having a first-degree family member with stomach cancer also raises your risk, and younger age at diagnosis or multiple family members with cancer may suggest a hereditary component worth discussing with your doctor.

How will eating change after stomach cancer surgery?

After stomach surgery, you’ll need to make significant dietary adjustments. You’ll need to eat smaller, more frequent meals—typically six to eight small meals throughout the day instead of three regular meals. Your body may not absorb nutrients as efficiently, so working with a dietitian is important. Some patients experience dumping syndrome, where food moves too quickly into the intestine, causing nausea, diarrhea, and sweating. Taking small bites, chewing thoroughly, and staying upright after eating can help manage these changes.

What is the difference between chemotherapy and immunotherapy for gastrointestinal cancer?

Chemotherapy uses drugs that directly kill rapidly dividing cancer cells but also affects some healthy cells, causing side effects. Immunotherapy works differently by helping your own immune system recognize and attack cancer cells. For stomach cancer, checkpoint inhibitors like pembrolizumab and nivolumab block proteins that prevent immune cells from attacking cancer. Immunotherapy tends to cause different side effects than chemotherapy and works particularly well in cancers with certain characteristics, like microsatellite instability or high PD-L1 expression.

🎯 Key takeaways

  • Gastrointestinal cancers encompass all cancers of the digestive tract, with colorectal cancer being the most common and treatable type in the United States when caught early.
  • Early detection dramatically improves survival—colorectal cancer caught before spreading is highly curable, while metastatic stomach cancer has only a 5% five-year survival rate.
  • Routine screening, particularly colonoscopy for colorectal cancer, can actually prevent cancer by removing precancerous polyps before they develop into malignancies.
  • Lifestyle factors including diet, exercise, smoking, alcohol consumption, and body weight significantly influence gastrointestinal cancer risk and are within your control to modify.
  • New immunotherapy and targeted therapy treatments have expanded options beyond traditional surgery, chemotherapy, and radiation, offering hope for better outcomes.
  • Living with gastrointestinal cancer requires significant adjustments to eating habits, physical activities, work life, and daily routines, but support resources exist to help maintain quality of life.
  • Family members play a critical role in supporting patients through treatment decisions, including clinical trial participation, and in providing practical and emotional assistance throughout the journey.
  • It’s possible to live without a stomach after surgery, though it requires learning new eating patterns and working closely with healthcare providers to maintain proper nutrition.